DK3801490T3 - Forbindelser til anvendelse i cancerkakeksi - Google Patents
Forbindelser til anvendelse i cancerkakeksi Download PDFInfo
- Publication number
- DK3801490T3 DK3801490T3 DK19730484.3T DK19730484T DK3801490T3 DK 3801490 T3 DK3801490 T3 DK 3801490T3 DK 19730484 T DK19730484 T DK 19730484T DK 3801490 T3 DK3801490 T3 DK 3801490T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- cancer cachexia
- cachexia
- cancer
- Prior art date
Links
- 206010006895 Cachexia Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Pediatric Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1809113.2A GB2575623B (en) | 2018-06-04 | 2018-06-04 | 3-hydroxybutyrate esters for treating cancer cachexia |
| PCT/GB2019/051532 WO2019234402A1 (en) | 2018-06-04 | 2019-06-03 | Compounds for use in cancer cachexia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3801490T3 true DK3801490T3 (da) | 2025-03-03 |
Family
ID=62872859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19730484.3T DK3801490T3 (da) | 2018-06-04 | 2019-06-03 | Forbindelser til anvendelse i cancerkakeksi |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US12226387B2 (https=) |
| EP (1) | EP3801490B1 (https=) |
| JP (1) | JP7402826B2 (https=) |
| KR (1) | KR102863322B1 (https=) |
| CN (1) | CN112384211B (https=) |
| CA (1) | CA3102503A1 (https=) |
| DK (1) | DK3801490T3 (https=) |
| ES (1) | ES3014285T3 (https=) |
| GB (1) | GB2575623B (https=) |
| PL (1) | PL3801490T3 (https=) |
| WO (1) | WO2019234402A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12396974B2 (en) | 2020-03-27 | 2025-08-26 | KetoneAid | Ketone ester as a therapeutic treatment of Covid-19 and related viral infections |
| CN118591523A (zh) * | 2021-11-12 | 2024-09-03 | 阿萨达股份公司 | 多元醇衍生的化合物 |
| KR20250145172A (ko) | 2024-03-28 | 2025-10-13 | 한림대학교 산학협력단 | 암 악액질의 예방 또는 치료를 위한 약학 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1648952B1 (en) * | 2003-06-03 | 2018-03-07 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives |
| EP3104396B1 (en) | 2003-06-13 | 2018-03-21 | Nikon Corporation | Exposure method, substrate stage, exposure apparatus, and device manufacturing method |
| JP5773870B2 (ja) * | 2008-08-21 | 2015-09-02 | アイシス イノヴェイション リミテッド | ヒドロキシ酪酸エステル及びその医学的使用 |
| US8642654B2 (en) * | 2009-04-16 | 2014-02-04 | Isis Innovation Limited | Hydroxybutyrate ester and medical use thereof |
| GB201002983D0 (en) | 2010-02-22 | 2010-04-07 | Tdeltas Ltd | Nutritinal composition |
| JP5269128B2 (ja) | 2010-03-12 | 2013-08-21 | エーエスエムエル ネザーランズ ビー．ブイ． | リソグラフィ装置および方法 |
| GB201206192D0 (en) * | 2012-04-05 | 2012-05-23 | Tdeltas Ltd | Ketone bodies and ketone body esters and for maintaining or improving muscle power output |
| WO2014085652A1 (en) | 2012-11-28 | 2014-06-05 | University Of South Florida | Targeting cancer with metabolic therapy and hyperbaric oxygen |
| GB201304467D0 (en) | 2013-03-12 | 2013-04-24 | Tdeltas Ltd | Compound for use in protecting skin |
| GB2515603B (en) | 2013-03-14 | 2015-10-14 | Isis Innovation | Process for producing (R)-3-Hydroxybutyl (R)-3-Hydroxybutyrate |
| GB201314127D0 (en) * | 2013-08-07 | 2013-09-18 | Tdeltas Ltd | Ketone body and ketone body ester for reducing muscle breakdown |
| WO2018114309A1 (en) * | 2016-12-23 | 2018-06-28 | Katholieke Universiteit Leuven | 3-hydroxybutyrate alone or in combination for use in the treatment of critical care treatment |
-
2018
- 2018-06-04 GB GB1809113.2A patent/GB2575623B/en active Active
-
2019
- 2019-06-03 WO PCT/GB2019/051532 patent/WO2019234402A1/en not_active Ceased
- 2019-06-03 DK DK19730484.3T patent/DK3801490T3/da active
- 2019-06-03 PL PL19730484.3T patent/PL3801490T3/pl unknown
- 2019-06-03 CA CA3102503A patent/CA3102503A1/en active Pending
- 2019-06-03 CN CN201980038028.5A patent/CN112384211B/zh active Active
- 2019-06-03 US US15/734,159 patent/US12226387B2/en active Active
- 2019-06-03 JP JP2020567530A patent/JP7402826B2/ja active Active
- 2019-06-03 KR KR1020217000016A patent/KR102863322B1/ko active Active
- 2019-06-03 EP EP19730484.3A patent/EP3801490B1/en active Active
- 2019-06-03 ES ES19730484T patent/ES3014285T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PL3801490T3 (pl) | 2025-04-14 |
| EP3801490B1 (en) | 2024-12-04 |
| CA3102503A1 (en) | 2019-12-12 |
| JP7402826B2 (ja) | 2023-12-21 |
| GB201809113D0 (en) | 2018-07-18 |
| US12226387B2 (en) | 2025-02-18 |
| CN112384211A (zh) | 2021-02-19 |
| JP2021525775A (ja) | 2021-09-27 |
| CN112384211B (zh) | 2025-01-03 |
| US20210212977A1 (en) | 2021-07-15 |
| ES3014285T3 (en) | 2025-04-21 |
| EP3801490A1 (en) | 2021-04-14 |
| GB2575623B (en) | 2022-10-26 |
| KR102863322B1 (ko) | 2025-09-22 |
| GB2575623A (en) | 2020-01-22 |
| WO2019234402A1 (en) | 2019-12-12 |
| KR20210019052A (ko) | 2021-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL282663A (en) | Bt1718 for use in treating cancer | |
| DK3902547T3 (da) | Csf1r-hæmmere til anvendelse i cancerbehandling | |
| IL283639A (en) | Kif18a inhibitors | |
| FIC20240013I1 (fi) | Lebrikitsumabi | |
| DK3431105T3 (da) | Medicinsk sammensætning til behandling af cancer | |
| DK3558997T3 (da) | Aminotriazolopyridinforbindelser og deres anvendelse til behandling af cancer | |
| DK3806898T3 (da) | Gremlin-1-antagonist til anvendelse i behandling af cancer | |
| DK3189082T3 (da) | Anti-pd-l1-konjugater til behandling af tumorer | |
| DK3594238T3 (da) | Antistofsammensætninger til tumorbehandling | |
| HUE059716T2 (hu) | RET inhibitorként jól használható vegyületek | |
| IL261047A (en) | Taf1 inhibitors for the therapy of cancer | |
| DK3400072T3 (da) | Formuleringer til behandling af blærecancer | |
| DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
| IL282330A (en) | Therapeutic compounds | |
| DK3353177T3 (da) | Tricykliske heterocykler til behandling af cancer | |
| LT3534885T (lt) | Farneziltransferazės inhibitoriai, skirti naudoti vėžio gydymui | |
| DK3386997T3 (da) | Monomaleimid-funktionaliserede platinforbindelser til cancerterapi | |
| IL281845A (en) | Combination therapy for the treatment of cancer | |
| DK3383385T3 (da) | Melflufen-doseringsregimer for cancer | |
| DK3478284T3 (da) | Forbindelser og sammensætninger til behandling af cancer | |
| IL281514A (en) | O-glycoprotein-2-acetamido-2-deoxy-3-d-glucopyranosidase inhibitors | |
| DK3389717T3 (da) | Neoadjuvansterapi for blærekræft | |
| DK3917538T3 (da) | Deoxycytidinderivater til anvendelse i cancerterapier | |
| DK3743721T3 (da) | Minaprin til anvendelse til reducering af tumorvækst | |
| DK3801490T3 (da) | Forbindelser til anvendelse i cancerkakeksi |